Navigation Links
ROX Medical secures financing and achieves key milestones in providing minimally-invasive approach for treating hypertension
Date:9/6/2012

SAN CLEMENTE, Calif., Sept. 6, 2012 /PRNewswire/ -- ROX Medical announced the closing of a financing round totaling $6M.  The financing will be used to initiate an international trial of the ROX FLOW procedure for the treatment of resistant hypertension (high blood pressure). Previously, ROX has successfully evaluated the FLOW procedure in pilot studies:  "The very encouraging results from our pilot hypertension trial was the basis for this investment, enabling us to pursue a more comprehensive, randomized study using the FLOW procedure," said CEO Rodney Brenneman.

According to the Centers for Disease Control, 68 million people in the US have high blood pressure and 1.2 billion people worldwide.  Of those, 50% of patients experience hypertension that remains uncontrolled (blood pressure above 140/90) and 15-20% have resistant form of hypertension. According to the American Heart Association, a 5 mmHg reduction in systolic blood pressure results in a 14% decrease in stroke, a 9% decrease in heart disease and a 7% decrease in overall mortality. 

ROX Medical's FLOW procedure is a short, minimally invasive, catheter-based procedure whereby Interventional Cardiologists, Radiologists or Endovascular Specialists place a stent-like connection between the artery and vein in the upper leg. The procedure is intended to reduce peripheral vascular resistance, thereby holding the promise of a meaningful long-term reduction in hypertension.  Uniquely, the FLOW procedure only involves the vascular structure, has an immediate effect; and is fully reversible.

To-date, ROX Medical has raised approximately $50M for its FLOW system, initially for studies and early commercialization of the FLOW procedure for COPD (pulmonary) treatment. The prior successful studies on COPD patients also demonstrated a significant lowering of blood pressure in hypertensive patients. "Hypertension physicians were encouraged by this response i
'/>"/>

SOURCE ROX Medical
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Ventana Medical Systems, Inc. develops first-ever fully automated dual-stain technique for miRNA and protein detection in cancer
2. Medical Alarm Retires Last of Convertible Preferred Stock
3. Concord Medical Responds to Unusual Market Activity in its Stock
4. International Spine Products Manufacturer Featured in Upcoming US Business Executive Publication - www.gsmedicalusa.com
5. Medical Alarm Provides Investor Update -- Company Surpassing Previous Record Order Levels as Consumer Interest Accelerates
6. MyEvaluations.com Launches New Medical Education Management Solutions That Meet ACGME NAS Accreditation Requirements
7. Fall Alert Announces Its New Medical Alert Systems Website
8. Surefire Medicals Infusion System For Embolization Procedures Receives CE Mark Approval
9. Magnalight Releases Handheld Infrared Light for Medical Applications
10. GHX Selects MicroStrategy to Offer Healthcare Suppliers Enhanced Access to Distributed Medical-Surgical Market Data
11. Sacred Heart Medical Center Deploys Talysts Pharmacy Automation for Inventory Control and Improved Patient Safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Most osteoporosis patients want a choice in the medication ... by Mission Pharmacal Company. The survey, conducted by ... community, revealed that 74 percent of osteoporosis patients surveyed ... other than a pill or a tablet. ...
(Date:1/15/2014)... N.J. , Jan. 15, 2014  Celsion Corporation (the "Company") ... has received commitments from institutional investors to purchase an ... stock in an at-the-market registered direct offering, led by ... entered into definitive purchase agreements with these investors pursuant ...
(Date:1/15/2014)... Jan. 15, 2014  Manufacturers, suppliers and distributors of ... to protect their most important business assets, intellectual ... ) Because of the highly-competitive nature ... one of the most litigious industry sectors of ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2
... N.J. and INDIANAPOLIS, March 29, 2011 Oral ... the updated clinical practice guidelines as a Class ... coronary intervention (PCI) after experiencing heart-related chest pain ... myocardial infarction (NSTEMI).  NSTEMI is a type of ...
... MicroCHIPS, Inc., a developer of innovative drug delivery devices ... and Trademark Office has granted U.S. Patent No. 7,892,221, ... patent in conjunction with U.S. Patent No. 7,070,590 provides ... medical devices used for implantable drug delivery systems. ...
Cached Medicine Technology:Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction 2Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction 3Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction 4Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction 5Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction 6MicroCHIPS Announces 35th U.S. Patent for Microreservoir-Based Drug Delivery Systems 2
(Date:4/23/2014)... frozen stool from healthy, unrelated donors was safe ... diarrhea caused by Clostridium difficile , according ... Clinical Infectious Diseases and available online. Known ... effective whether given via a colonoscope or a ... make this promising treatment more readily available to ...
(Date:4/23/2014)... looking to give exercise enthusiasts the extra nudge they ... that a cyber buddy can help. , The study, ... , is the first to indicate that although a ... a software-generated partner also can be effective. , "We ... still motivate people to give greater effort while exercising ...
(Date:4/23/2014)... compound that targets an important brain receptor has a ... including relapse behavior, a University at Buffalo animal study ... this may be a novel lead compound for treating ... UB research was published as an online preview article ... study, the compound, RO5263397, severely blunted a broad range ...
(Date:4/23/2014)... (April 23, 2014) The American Gastroenterological Association ... 2014 AGA Research Scholars. The AGA Research Scholar ... to develop independent and productive research careers in ... Awards fund an additional year allowing for three ... to supporting junior faculty who are paving the ...
(Date:4/23/2014)... A team of scientists led by a researcher from ... the National University of Singapore has identified the cancer ... opens up the possibility of developing new drugs for ... cancers. , The research group, led by Dr Chan ... for the first time that a cancer-specific variant of ...
Breaking Medicine News(10 mins):Health News:Pilot study suggests ways to widen access to fecal transplants for C. diff infections 2Health News:Cyber buddy is better than 'no buddy' 2Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:AGA announces 2014 Class of AGA Research Scholars 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3
... has the second most populous Jewish community in America, ... Florida for economic opportunities, for the climate, to join ... growing Jewish population of Broward County is now declining ... University of Miami professor Dr. Ira M. Sheskin, from ...
... March 10 A recent CBS 60 Minutes ... a red wine molecule believed to largely be ... French have far more people living beyond 100 ... from heart disease than other people living in ...
... , , TUESDAY, March 10 (HealthDay News) -- The chances of ... that sells alcohol to go, according to a study by ... and around off-premise alcohol outlets were shot as the victims ... were easier targets or they were shot as the victims ...
... Omega Protein Corporation (NYSE: OME ), the ... fish meal products, today reported net income of $12.6 ... December 31, 2008, compared with net income of $12.1 ... 31, 2007.(Logo: http://www.newscom.com/cgi-bin/prnh/20030516/OMEGALOGO )For the year ended ...
... LAKEWOOD, Colo., March 10 Mesa Laboratories, Inc. ... consumables for healthcare and manufacturing quality control applications, today announced ... of Chief Executive Officer (CEO), replacing Luke R. Schmieder, who ... Mr. Schmieder is retiring from Mesa and resigning his ...
... of packaging traceability posed by regulated medical wasteCLEVELAND, ... a leader in label, packaging , promotion ... placard identification reusable labeling solution to meet stringent ... containers for biomedical waste. Subject to governmental regulations, ...
Cached Medicine News:Health News:UM study reveals demographic trend of the Jewish population in Broward County 2Health News:Researchers Report Combined Molecules in Red Wine by Far Exceed the Biological Activity of Plain Resveratrol, Consistent With the Composition of Longevinex(R) 2Health News:Researchers Report Combined Molecules in Red Wine by Far Exceed the Biological Activity of Plain Resveratrol, Consistent With the Composition of Longevinex(R) 3Health News:Shootings Linked to Alcohol-to-Go Outlets, Study Finds 2Health News:Omega Protein Reports 2008 Results 2Health News:Omega Protein Reports 2008 Results 3Health News:Omega Protein Reports 2008 Results 4Health News:Omega Protein Reports 2008 Results 5Health News:Mesa Labs Announces the Appointment of New CEO 2Health News:Mesa Labs Announces the Appointment of New CEO 3Health News:Kennedy Group Applies Its Packaging Expertise to Reusable Labeling in Handling Biomedical Waste Disposal 2Health News:Kennedy Group Applies Its Packaging Expertise to Reusable Labeling in Handling Biomedical Waste Disposal 3Health News:Kennedy Group Applies Its Packaging Expertise to Reusable Labeling in Handling Biomedical Waste Disposal 4
... surgical approach to glaucoma management that employs ... ciliary body (which produces aqueous humour) is ... or posterior segment, through the endoscope in ... and accurately identified utilizing endoscopy. This allows ...
... of German Craftsmanship have produced ... the world. Ocutek® now makes ... holders of the coveted Meisterbrief ... apprenticeship, are qualified to become ...
... Craftsmanship have produced the finest ... Ocutek® now makes them available ... the coveted Meisterbrief certificate, which ... qualified to become Ocutek instrument ...
... Craftsmanship have produced the finest ... Ocutek® now makes them available ... the coveted Meisterbrief certificate, which ... qualified to become Ocutek instrument ...
Medicine Products: